Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 8518945, 11 pages
http://dx.doi.org/10.1155/2016/8518945
Review Article

Biomolecular Network-Based Synergistic Drug Combination Discovery

1Key Laboratory of Quality and Safety Risk Assessment for Aquatic Products on Storage and Preservation (Shanghai), China Ministry of Agriculture, College of Food Science and Technology, Shanghai Ocean University, 999 Hu Cheng Huan Road, Shanghai 201306, China
2Shanghai Center for Bioinformation Technology, Shanghai Academy of Science and Technology, 1278 Keyuan Road, Shanghai 201203, China

Received 24 June 2016; Revised 20 September 2016; Accepted 11 October 2016

Academic Editor: Zhongjie Liang

Copyright © 2016 Xiangyi Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Hopkins, “Network pharmacology: the next paradigm in drug discovery,” Nature Chemical Biology, vol. 4, no. 11, pp. 682–690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. DiMasi, H. G. Grabowski, and R. W. Hansen, “Innovation in the pharmaceutical industry: new estimates of R&D costs,” Journal of Health Economics, vol. 47, pp. 20–33, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Holohan, S. Van Schaeybroeck, D. B. Longley, and P. G. Johnston, “Cancer drug resistance: an evolving paradigm,” Nature Reviews Cancer, vol. 13, no. 10, pp. 714–726, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Kumar, K. Chaudhary, S. Gupta et al., “CancerDR: cancer drug resistance database,” Scientific Reports, vol. 3, article 1445, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. N. J. Sucher, “Searching for synergy in silico, in vitro and in vivo,” Synergy, vol. 1, no. 1, pp. 30–43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. T.-C. Chou, “Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies,” Pharmacological Reviews, vol. 58, no. 3, pp. 621–681, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. C. Berenbaum, “What is synergy?” Pharmacological Reviews, vol. 41, no. 2, pp. 93–141, 1989. View at Google Scholar · View at Scopus
  8. S. Loewe, “The problem of synergism and antagonism of combined drugs,” Arzneimittel-Forschung, vol. 3, no. 6, pp. 285–290, 1953. View at Google Scholar · View at Scopus
  9. C. I. Bliss, “The toxicity of poisons applied jointly,” Annals of Applied Biology, vol. 26, no. 3, pp. 585–615, 1939. View at Publisher · View at Google Scholar
  10. B. Yadav, K. Wennerberg, T. Aittokallio, and J. Tang, “Searching for drug synergy in complex dose–response landscapes using an interaction potency model,” Computational and Structural Biotechnology Journal, vol. 13, pp. 504–513, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. T.-C. Chou, “Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands,” Journal of Theoretical Biology, vol. 59, no. 2, pp. 255–276, 1976. View at Publisher · View at Google Scholar
  12. T.-C. Chou, “Drug combination studies and their synergy quantification using the Chou-Talalay method,” Cancer Research, vol. 70, no. 2, pp. 440–446, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. X.-M. Zhao, M. Iskar, G. Zeller, M. Kuhn, V. Van Noort, and P. Bork, “Prediction of drug combinations by integrating molecular and pharmacological data,” PLoS Computational Biology, vol. 7, no. 12, Article ID e1002323, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Van De Waterbeemd and E. Gifford, “ADMET in silico modelling: towards prediction paradise?” Nature Reviews Drug Discovery, vol. 2, no. 3, pp. 192–204, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Ekins, “Predicting undesirable drug interactions with promiscuous proteins in silico,” Drug Discovery Today, vol. 9, no. 6, pp. 276–285, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Ekins, A. J. Williams, M. D. Krasowski, and J. S. Freundlich, “In silico repositioning of approved drugs for rare and neglected diseases,” Drug Discovery Today, vol. 16, no. 7-8, pp. 298–310, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Al-Lazikani, U. Banerji, and P. Workman, “Combinatorial drug therapy for cancer in the post-genomic era,” Nature Biotechnology, vol. 30, no. 7, pp. 679–692, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. A.-L. Barabási, N. Gulbahce, and J. Loscalzo, “Network medicine: a network-based approach to human disease,” Nature Reviews Genetics, vol. 12, no. 1, pp. 56–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A.-L. Barabási and Z. N. Oltvai, “Network biology: understanding the cell's functional organization,” Nature Reviews Genetics, vol. 5, no. 2, pp. 101–113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Chen, R.-S. Wang, and X.-S. Zhang, Biomolecular Networks: Methods and Applications in Systems Biology, vol. 10, John Wiley & Sons, New York, NY, USA, 2009.
  21. Z.-P. Liu, Y. Wang, X.-S. Zhang, and L. Chen, “Network-based analysis of complex diseases,” IET Systems Biology, vol. 6, no. 1, pp. 22–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Chen, R. Wang, C. Li, and K. Aihara, Modeling Biomolecular Networks in Cells: Structures and Dynamics, Springer Science & Business Media, 2010.
  23. J. Ruan, A. K. Dean, and W. Zhang, “A general co-expression network-based approach to gene expression analysis: comparison and applications,” BMC Systems Biology, vol. 4, article 8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. A. Reuter, D. V. Spacek, and M. P. Snyder, “High-throughput sequencing technologies,” Molecular Cell, vol. 58, no. 4, pp. 586–597, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Chou and N. Martin, CompuSyn for Drug Combinations: PC Software and User's Guide: A Computer Program for Quantitation of Synergism and Antagonism in Drug Combinations, and the Determination of IC50 and ED50 and LD50 Values, ComboSyn, Paramus, NJ, USA, 2005.
  26. L. He, E. Kulesskiy, J. Saarela et al., “Methods for high-throughput drug combination screening and synergy scoring,” BioRxiv, 2016. View at Publisher · View at Google Scholar
  27. J. C. Boik and B. Narasimhan, “An R package for assessing drug synergism/antagonism,” Journal of Statistical Software, vol. 34, no. 6, pp. 1–18, 2010. View at Google Scholar · View at Scopus
  28. M. Kashif, “Synergy/Antagonism Analyses of Drug Combinations,” R package version 104, 2015
  29. M. Prichard, K. Aseltine, and C. Shipman Jr., MacSynergy II. Version 1.0. User's Manual, University of Michigan, Ann Arbor, Mich, USA, 1993.
  30. G. Y. Di Veroli, C. Fornari, D. Wang et al., “Combenefit: an interactive platform for the analysis and visualization of drug combinations,” Bioinformatics, vol. 32, no. 18, pp. 2866–2868, 2016. View at Publisher · View at Google Scholar
  31. J.-H. Lee, D. G. Kim, T. J. Bae et al., “CDA: combinatorial drug discovery using transcriptional response modules,” PLoS ONE, vol. 7, no. 8, Article ID e42573, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Lewis, R. Guha, T. Korcsmaros, and A. Bender, “Synergy Maps: exploring compound combinations using network-based visualization,” Journal of Cheminformatics, vol. 7, no. 1, article 36, 11 pages, 2015. View at Publisher · View at Google Scholar
  33. S. Alaimo, V. Bonnici, D. Cancemi, A. Ferro, R. Giugno, and A. Pulvirenti, “DT-Web: a web-based application for drug-target interaction and drug combination prediction through domain-tuned network-based inference,” BMC Systems Biology, vol. 9, no. 3, p. 1, 2015. View at Google Scholar
  34. L. He, K. Wennerberg, T. Aittokallio, and J. Tang, “TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples,” Bioinformatics, vol. 31, no. 11, pp. 1866–1868, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Liu, Q. Wei, G. Yu, W. Gai, Y. Li, and X. Chen, “DCDB 2.0: a major update of the drug combination database,” Database, vol. 2014, Article ID bau124, 2014. View at Publisher · View at Google Scholar
  36. F. Zhu, B. Han, P. Kumar et al., “Update of TTD: therapeutic target database,” Nucleic Acids Research, vol. 38, supplement 1, pp. D787–D791, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Y.-C. Chen, “TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico,” PLoS ONE, vol. 6, no. 1, Article ID e15939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. X. Chen, B. Ren, M. Chen et al., “ASDCD: antifungal synergistic drug combination database,” PLoS ONE, vol. 9, no. 1, article e86499, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Szklarczyk, A. Franceschini, M. Kuhn et al., “The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored,” Nucleic Acids Research, vol. 39, no. 1, pp. D561–D568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Joshi-Tope, M. Gillespie, I. Vastrik et al., “Reactome: a knowledgebase of biological pathways,” Nucleic Acids Research, vol. 33, supplement 1, pp. D428–D432, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Kanehisa and S. Goto, “KEGG: kyoto encyclopedia of genes and genomes,” Nucleic Acids Research, vol. 28, no. 1, pp. 27–30, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Stark, B.-J. Breitkreutz, T. Reguly, L. Boucher, A. Breitkreutz, and M. Tyers, “BioGRID: a general repository for interaction datasets,” Nucleic Acids Research, vol. 34, supplement 1, pp. D535–539, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Kuhn, D. Szklarczyk, A. Franceschini, C. Von Mering, L. J. Jensen, and P. Bork, “STITCH 3: zooming in on protein-chemical interactions,” Nucleic Acids Research, vol. 40, no. 1, pp. D876–D880, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Baolin and H. Bo, “HPRD: a high performance RDF database,” in Network and Parallel Computing: IFIP International Conference, NPC 2007, Dalian, China, September 18–21, 2007. Proceedings, vol. 4672 of Lecture Notes in Computer Science, pp. 364–374, Springer, Berlin, Germany, 2007. View at Publisher · View at Google Scholar
  45. I. Xenarios, Ł. Salwínski, X. J. Duan, P. Higney, S.-M. Kim, and D. Eisenberg, “DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions,” Nucleic Acids Research, vol. 30, no. 1, pp. 303–305, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Kerrien, B. Aranda, L. Breuza et al., “The IntAct molecular interaction database in 2012,” Nucleic Acids Research, vol. 40, no. 1, Article ID gkr1088, pp. D841–D846, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Kelder, M. P. Van Iersel, K. Hanspers et al., “WikiPathways: building research communities on biological pathways,” Nucleic Acids Research, vol. 40, no. D1, pp. D1301–D1307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Jiang, Z. Xuan, F. Zhao, and M. Q. Zhang, “TRED: a transcriptional regulatory element database, new entries and other development,” Nucleic Acids Research, vol. 35, no. 1, pp. D137–D140, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. S.-K. Ng, Z. Zhang, S.-H. Tan, and K. Lin, “InterDom: a database of putative interacting protein domains for validating predicted protein interactions and complexes,” Nucleic Acids Research, vol. 31, no. 1, pp. 251–254, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Fazekas, M. Koltai, D. Türei et al., “SignaLink 2—a signaling pathway resource with multi-layered regulatory networks,” BMC Systems Biology, vol. 7, article 7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Lamb, E. D. Crawford, D. Peck et al., “The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease,” Science, vol. 313, no. 5795, pp. 1929–1935, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Frantz, “Drug discovery: playing dirty,” Nature, vol. 437, no. 7061, pp. 942–943, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. P. Li, Y. Fu, and Y. Wang, “Network based approach to drug discovery: a mini review,” Mini-Reviews in Medicinal Chemistry, vol. 15, no. 8, pp. 687–695, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Yin, W. Ma, J. Pei, Q. Ouyang, C. Tang, and L. Lai, “Synergistic and antagonistic drug combinations depend on network topology,” PLoS ONE, vol. 9, no. 4, article e93960, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. C. P. Goswami, L. Cheng, P. S. Alexander, A. Singal, and L. Li, “A new drug combinatory effect prediction algorithm on the cancer cell based on gene expression and dose-response curve,” CPT: Pharmacometrics and Systems Pharmacology, vol. 4, no. 2, pp. 80–90, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. J. L. DeRisi, V. R. Iyer, and P. O. Brown, “Exploring the metabolic and genetic control of gene expression on a genomic scale,” Science, vol. 278, no. 5338, pp. 680–686, 1997. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Lamb, S. Ramaswamy, H. L. Ford et al., “A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer,” Cell, vol. 114, no. 3, pp. 323–334, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Huang, F. Li, J. Sheng et al., “DrugComboRanker: drug combination discovery based on target network analysis,” Bioinformatics, vol. 30, no. 12, pp. I228–I236, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. V. Y. Tan and C. Févotte, “Automatic relevance determination in nonnegative matrix factorization with the/spl beta/-divergence,” IEEE Transactions on Pattern Analysis and Machine Intelligence, vol. 35, no. 7, pp. 1592–1605, 2013. View at Publisher · View at Google Scholar
  60. G. Jin, H. Zhao, X. Zhou, and S. T. C. Wong, “An enhanced Petri-Net model to predict synergistic effects of pairwise drug combinations from gene microarray data,” Bioinformatics, vol. 27, no. 13, pp. i310–i316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. Z. Wu, X.-M. Zhao, and L. Chen, “A systems biology approach to identify effective cocktail drugs,” BMC Systems Biology, vol. 4, no. 2, article 7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. D. Chen, H. Zhang, P. Lu, X. Liu, and H. Cao, “Synergy evaluation by a pathway–pathway interaction network: a new way to predict drug combination,” Molecular BioSystems, vol. 12, no. 2, pp. 614–623, 2016. View at Publisher · View at Google Scholar
  63. M. Bansal, J. Yang, C. Karan et al., “A community computational challenge to predict the activity of pairs of compounds,” Nature Biotechnology, vol. 32, no. 12, pp. 1213–1222, 2014. View at Publisher · View at Google Scholar
  64. J. Zhao, X.-S. Zhang, and S. Zhang, “Predicting cooperative drug effects through the quantitative cellular profiling of response to individual drugs,” CPT: Pharmacometrics & Systems Pharmacology, vol. 3, no. 2, article 79, pp. 1–7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. R. B. Altman, “Predicting cancer drug response: advancing the DREAM,” Cancer Discovery, vol. 5, no. 3, pp. 237–238, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Yang, H. Tang, Y. Li et al., “DIGRE: drug-induced genomic residual effect model for successful prediction of multidrug effects,” CPT: Pharmacometrics and Systems Pharmacology, vol. 4, no. 2, pp. 91–97, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. X. Zhu, “Semi-supervised learning literature survey,” Computer Science, vol. 37, no. 1, pp. 63–77, 2008. View at Google Scholar
  68. Y. Sun, Z. Sheng, C. Ma et al., “Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer,” Nature Communications, vol. 6, article 9481, 2015. View at Publisher · View at Google Scholar · View at Scopus
  69. D. Zhou, J. Weston, O. Bousquet, and B. Scholkopf, “Ranking on data manifolds,” in Neural Information Processing Systems, 2004. View at Google Scholar
  70. X. Chen, B. Ren, M. Chen et al., “NLLSS: predicting synergistic drug combinations based on semi-supervised learning,” PLOS Computational Biology, vol. 12, no. 7, Article ID e1004975, 2016. View at Publisher · View at Google Scholar
  71. M. Belkin, P. Niyogi, and V. Sindhwani, “Manifold regularization: a geometric framework for learning from labeled and unlabeled examples,” Journal of Machine Learning Research, vol. 7, pp. 2399–2434, 2006. View at Google Scholar · View at MathSciNet
  72. M. Mohri, A. Rostamizadeh, and A. Talwalkar, Foundations of Machine Learning, MIT Press, Boston, Mass, USA, 2012.
  73. K.-J. Xu, F.-Y. Hu, J. Song, and X.-M. Zhao, “Exploring drug combinations in a drug-cocktail network,” in Proceedings of the 5th IEEE International Conference on Systems Biology (ISB '11), pp. 382–387, Zhuhai, China, September 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. P. Li, C. Huang, Y. Fu et al., “Large-scale exploration and analysis of drug combinations,” Bioinformatics, vol. 31, no. 12, pp. 2007–2016, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. R. Jansen, H. Yu, D. Greenbaum et al., “A Bayesian networks approach for predicting protein-protein interactions from genomic data,” Science, vol. 302, no. 5644, pp. 449–453, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Chandrasekaran, M. Cokol‐Cakmak, N. Sahin et al., “Chemogenomics and orthology‐based design of antibiotic combination therapies,” Molecular Systems Biology, vol. 12, no. 5, p. 872, 2016. View at Publisher · View at Google Scholar
  77. J. Lehar, A. Krueger, W. Avery et al., “Synergistic drug combinations tend to improve therapeutically relevant selectivity,” Nature Biotechnology, vol. 27, no. 7, p. 659, 2009. View at Publisher · View at Google Scholar
  78. Z. Wu, Y. Wang, and L. Chen, “Network-based drug repositioning,” Molecular BioSystems, vol. 9, no. 6, pp. 1268–1281, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. Y.-Y. Wang, K.-J. Xu, J. Song, and X.-M. Zhao, “Exploring drug combinations in genetic interaction network,” BMC Bioinformatics, vol. 13, supplement 7, article S7, 2012. View at Publisher · View at Google Scholar
  80. Y. Liu and H. Zhao, “Predicting synergistic effects between compounds through their structural similarity and effects on transcriptomes,” Bioinformatics, 2016. View at Publisher · View at Google Scholar
  81. W. Hassen, A. Kassambara, T. Reme et al., “Drug metabolism and clearance system in tumor cells of patients with multiple myeloma,” Oncotarget, vol. 6, no. 8, pp. 6431–6447, 2015. View at Publisher · View at Google Scholar · View at Scopus
  82. R. L. Juliano and V. Ling, “A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants,” Biochimica et Biophysica Acta, vol. 445, no. 1, pp. 152–162, 1976. View at Google Scholar · View at Scopus
  83. M. M. Gottesman, “Mechanisms of cancer drug resistance,” Annual Review of Medicine, vol. 53, pp. 615–627, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. H. Glavinas, P. Krajcsi, J. Cserepes, and B. Sarkadi, “The role of ABC transporters in drug resistance, metabolism and toxicity,” Current Drug Delivery, vol. 1, no. 1, pp. 27–42, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. P. Borst, R. Evers, M. Kool, and J. Wijnholds, “A family of drug transporters: the multidrug resistance-associated proteins,” Journal of the National Cancer Institute, vol. 92, no. 16, pp. 1295–1302, 2000. View at Publisher · View at Google Scholar · View at Scopus
  86. G. Szakács, J. K. Paterson, J. A. Ludwig, C. Booth-Genthe, and M. M. Gottesman, “Targeting multidrug resistance in cancer,” Nature Reviews Drug Discovery, vol. 5, no. 3, pp. 219–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Morishita, T. Yamagata, H. Kusuhara, K. Takayama, and Y. Sugiyama, “Use of pharmaceutical excipients in enhancing GI absorption by inhibiting efflux transporters,” in Proceedings of the Asian Pacific Regional International Society for the Study of Xenobiotics Meeting, pp. 119–130, 1972.
  88. V. Y. Chua, J. Harvey, and J. Bentel, “Abstract 715: regulation of the ABCG2 drug efflux transporter in breast cancer cells,” Cancer Research, vol. 75, no. 15, supplement, pp. 715–715, 2015. View at Publisher · View at Google Scholar
  89. G. Pan, T. Li, Q. Zeng, X. Wang, and Y. Zhu, “Alisol F 24 acetate enhances chemosensitivity and apoptosis of MCF-7/DOX Cells by inhibiting P-glycoprotein-mediated drug efflux,” Molecules, vol. 21, no. 2, 2016. View at Google Scholar
  90. M. A. Reis, O. B. Ahmed, G. Spengler, J. Molnár, H. Lage, and M. U. Ferreira, “Jatrophane diterpenes and cancer multidrug resistance—ABCB1 efflux modulation and selective cell death induction,” Phytomedicine, vol. 23, no. 9, pp. 968–978, 2016. View at Publisher · View at Google Scholar
  91. L. Lin, S. W. Yee, R. B. Kim, and K. M. Giacomini, “SLC transporters as therapeutic targets: emerging opportunities,” Nature Reviews Drug Discovery, vol. 14, no. 8, pp. 543–560, 2015. View at Publisher · View at Google Scholar · View at Scopus